Significance of Residual Inflammatory Risk and Persistent Inflammation in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries
Residual inflammation but not cholesterol risk drives poorer outcomes after MINOCA in the statin era, highlighting inflammation as a pivotal risk predictor and the necessity for anti-inflammatory strategies alongside LDL-C lowering.
Authors
- Sizhuang Huang
- Side Gao (ORCID: https://orcid.org/0000-0002-8817-3699)
- Xinming Liu (ORCID: https://orcid.org/0000-0001-6328-4803)
- Wei‐Ming Li (ORCID: https://orcid.org/0000-0001-6155-0696)
- Mengyue Yu (ORCID: https://orcid.org/0000-0003-3004-8948)
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/jir.s547594
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00